Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) · 2025
Evaluation of domain shift sources and generalisability in AI-based prostate MRI autocontouring for radiotherapy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alqarni Maram, Jones Emma-Louise, Mullassery Vinod, Morris Stephen, Harana Jorge Mariscal, Antón Esther Puyol, Cooper Sian, Verma Hema, Urbano Teresa Guerrero, King Andrew P
Аннотация
AIM: Deep learning (DL) models have been widely proposed to automate MRI-based delineation, but their use is hindered by differences in image characteristics between training and evaluation datasets (i.e. domain shift). This paper aims to (i) analyse the impacts of different sources of domain shift and (ii) externally evaluate a model trained using heterogeneous public data and compare it with an in-house model.
METHODS: The nnU-Net DL framework was trained for prostate autocontouring using axial T2-weighted (T2W) prostate MRIs from five public datasets. By controlling training set size, three sources of domain shift were evaluated: dataset, scanner vendor/field strength, and image acquisition/annotation protocol. 66 prostate MRIs were used for external evaluation and training/evaluation of an in-house model. The Dice Similarity Coefficient (DSC) and 95 % Hausdorff distance (HD) evaluated the model-produced contours.
RESULTS: The performance gap (Δ) between intra/inter-domain evaluation showed that domain shift from scanner vendor/field strength (ΔDSC = 0.33, Δ95 % HD = 246.86 mm) and image acquisition/annotation protocols (ΔDSC = 0.20, Δ95 % HD = 14.70 mm) had greater impact than that from dataset (ΔDSC = 0.06, Δ95 % HD = 3.69 mm), although all were significant (p < 0.05). External evaluation showed that the mixed-domain trained model performed well but was less robust than the in-house model (median (IQR) DSC/95 % HD = 0.87 (0.06)/3.75 (4.47)mm, 0.90 (0.03)/1.03 (1.29) mm, p < 0.05, respectively).
CONCLUSIONS: We highlight for the first time the domain shift effect of image acquisition/annotation protocol, even with images acquired using the same scanner vendor/field strength. Understanding the effect of multiple sources of domain shift has enabled us to train a robust model that can be safely clinically deployed.
METHODS: The nnU-Net DL framework was trained for prostate autocontouring using axial T2-weighted (T2W) prostate MRIs from five public datasets. By controlling training set size, three sources of domain shift were evaluated: dataset, scanner vendor/field strength, and image acquisition/annotation protocol. 66 prostate MRIs were used for external evaluation and training/evaluation of an in-house model. The Dice Similarity Coefficient (DSC) and 95 % Hausdorff distance (HD) evaluated the model-produced contours.
RESULTS: The performance gap (Δ) between intra/inter-domain evaluation showed that domain shift from scanner vendor/field strength (ΔDSC = 0.33, Δ95 % HD = 246.86 mm) and image acquisition/annotation protocols (ΔDSC = 0.20, Δ95 % HD = 14.70 mm) had greater impact than that from dataset (ΔDSC = 0.06, Δ95 % HD = 3.69 mm), although all were significant (p < 0.05). External evaluation showed that the mixed-domain trained model performed well but was less robust than the in-house model (median (IQR) DSC/95 % HD = 0.87 (0.06)/3.75 (4.47)mm, 0.90 (0.03)/1.03 (1.29) mm, p < 0.05, respectively).
CONCLUSIONS: We highlight for the first time the domain shift effect of image acquisition/annotation protocol, even with images acquired using the same scanner vendor/field strength. Understanding the effect of multiple sources of domain shift has enabled us to train a robust model that can be safely clinically deployed.